Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 33.4 Cr.
- Current Price ₹ 13.5
- High / Low ₹ 21.2 / 6.65
- Stock P/E 13.2
- Book Value ₹ 44.6
- Dividend Yield 0.00 %
- ROCE 3.28 %
- ROE 2.30 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.30 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 19.5%
- Company has a low return on equity of 1.72% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.06 | 81.90 | 81.84 | |
| 30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 71.92 | 76.81 | 76.61 | |
| Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.14 | 5.09 | 5.23 |
| OPM % | 27.63% | 6.04% | 16.97% | 4.35% | 6.29% | 4.18% | 6.21% | 6.39% |
| 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | |
| Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.07 | 0.37 | 0.50 |
| Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.46 | 1.45 |
| Profit before tax | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 1.63 | 3.27 | 3.31 |
| Tax % | 0.39% | 25.00% | 40.00% | 31.82% | 33.03% | 28.83% | 23.85% | |
| 10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.16 | 2.49 | 2.53 | |
| EPS in Rs | 6.42 | 0.25 | 0.20 | 0.18 | 0.73 | 0.50 | 1.01 | 1.02 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 22% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 100% |
| TTM: | 146% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -12% |
| 3 Years: | -18% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 60.52 | 60.91 | 61.23 | 64.52 | 76.53 | 82.97 | 85.51 |
| 0.87 | 1.03 | 1.25 | 1.61 | 1.90 | 1.15 | 3.96 | |
| 15.89 | 14.61 | 12.44 | 13.62 | 9.24 | 17.38 | 34.69 | |
| Total Liabilities | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 | 148.91 |
| 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 15.02 | |
| CWIP | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 37.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 33.84 | 72.32 | 72.10 | 79.94 | 92.36 | 110.55 | 133.89 | |
| Total Assets | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 | 148.91 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 2.68 | 0.22 | -0.57 | -6.76 | -12.55 | -6.43 | -3.62 | |
| -1.94 | -0.07 | -0.05 | 0.27 | -0.30 | -0.14 | -2.25 | |
| -1.77 | -0.37 | 0.07 | 5.26 | 14.04 | 7.52 | 3.96 | |
| Net Cash Flow | -1.03 | -0.22 | -0.56 | -1.23 | 1.19 | 0.95 | -1.91 |
| Free Cash Flow | 0.87 | 0.06 | -0.63 | -6.51 | -12.86 | -6.57 | -5.86 |
| CFO/OP | 23% | 18% | -6% | -334% | -311% | -204% | -71% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 60.98 | 75.72 |
| Inventory Days | 0.00 | 890.81 | 1,182.75 | 683.64 | 445.05 | 327.35 | 340.22 |
| Days Payable | 112.09 | 147.78 | 123.28 | 41.68 | 69.00 | 143.23 | |
| Cash Conversion Cycle | 177.66 | 913.46 | 1,176.04 | 657.58 | 463.81 | 319.32 | 272.71 |
| Working Capital Days | 421.77 | 545.99 | 603.01 | 507.69 | 477.19 | 423.01 | 418.97 |
| ROCE % | 0.81% | 5.62% | 0.68% | 2.53% | 1.65% | 3.28% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Employee Count number ・Standalone data |
|
|||||||
| Product Portfolio Count number ・Standalone data |
||||||||
| E-commerce Consumer Base number ・Standalone data |
||||||||
| Influencer / PIP Count number ・Standalone data |
||||||||
| Foreign Distributors Count number ・Standalone data |
||||||||
| Direct Wellness Consultants (DWC) Count number ・Standalone data |
||||||||
| Home Shops (HS) Count number ・Standalone data |
||||||||
| Number of States of Operation number ・Standalone data |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Copy of Newspaper Publication made for submission of Unaudited Financial Results (Standalone & Consolidated) of the company for the quarter ended June 30, 2026.
- Un-Audited Financial Results For The Quarter Ended June 30, 2026
-
Board Meeting Outcome for Outcome Of Board Meeting
- Q1 FY27 unaudited standalone and consolidated results approved on 14 Aug 2026; standalone PAT Rs24.63 lakh, consolidated Rs29.11 lakh.
-
Board Meeting Intimation for Consider And Approve, The Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30Th, 2026.
- Board meeting on 14 August 2026 to approve Q1 FY27 standalone and consolidated results.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- EGM voting results filed for July 24, 2026 meeting; three independent director appointments approved.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com